Gunnar Telhammar
Directeur Financier/CFO chez XINTELA AB
Postes actifs de Gunnar Telhammar
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| XINTELA AB | Directeur Financier/CFO | 01/01/2013 | - |
| ACOUSORT AB | Directeur Financier/CFO | 01/01/2016 | - |
| LIFEASSAYS AB (PUBL) | Directeur Financier/CFO | - | - |
| TENDO AB | Directeur Financier/CFO | - | - |
| SENSODETECT AKTIEBOLAG | Directeur Financier/CFO | - | - |
ImmuneBiotech Medical Sweden AB
 ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | Directeur Financier/CFO | - | - |
| BioFinans AB | Directeur/Membre du Conseil | 01/01/2004 | - |
| Directeur Général | 01/01/2004 | - | |
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Directeur Financier/CFO | 01/01/2019 | - |
| Directeur/Membre du Conseil | 01/01/2019 | - |
Historique de carrière de Gunnar Telhammar
Anciens postes connus de Gunnar Telhammar
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Telepartner AS (Norway) | Directeur Financier/CFO | 01/01/1990 | 01/01/1996 |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Gunnar Telhammar
| University of Lund | Graduate Degree |
Statistiques
Internationale
| Suède | 14 |
| Norvège | 2 |
Opérationnelle
| Director of Finance/CFO | 11 |
| Director/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectorielle
| Health Technology | 9 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| SENSODETECT AKTIEBOLAG | Commercial Services |
| GUARD THERAPEUTICS INTERNATIONAL AB | Health Technology |
| ACOUSORT AB | Distribution Services |
| XINTELA AB | Health Technology |
| BIBBINSTRUMENTS AB | Health Technology |
| AEGIRBIO AB | Health Technology |
| TENDO AB | Health Technology |
| Entreprise privées | 6 |
|---|---|
LifeAssays AB
 LifeAssays AB Medical SpecialtiesHealth Technology LifeAssays AB is a diagnostic company, which engages in the provision of point-of-care diagnostic testing for veterinarians, community health centers and primary physicians. It's products include own produced instruments and disposable agents as well as blood analysis systems LifeAssays Reader and LifeAssays VetReader. The company was founded on August 17, 2000 and is headquartered in Lund, Sweden. | Health Technology |
| Preelumina Diagnostics AB | |
ImmuneBiotech Medical Sweden AB
ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | Health Technology |
Targinta AB
Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Health Technology |
| BioFinans AB | |
| Telepartner AS (Norway) |
- Bourse
- Insiders
- Gunnar Telhammar
- Expérience